Elisabetta Antonioli

7PUBLICATIONS
16CO-AUTHORS
Major global burdens of diseaseNanomedicineGene and molecular therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma.

|Nov 26, 2024
Clinical Presentation and Long-Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study.

K Mancuso, R Mina, S Rocchi

|Oct 11, 2024

Irene Attucci, Sofia Pilerci, Maria Messeri

|Mar 25, 2022
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network).

Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda

|Aug 11, 2020
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience.

Elisabetta Antonioli, Michela Staderini, Sofia Pilerci

|Nov 26, 2019
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.

Elisabetta Antonioli, Chiara Nozzoli, Gabriele Buda

Pageof 2

Frequent Collaborators

2 joint publications

Alessandro Gozzetti

1 joint publications

K Mancuso

1 joint publications

S Barbato

1 joint publications

P Tacchetti